Log in
Enquire now
‌

US Patent 11053280 Anti-VEGF protein compositions and methods for producing the same

Patent 11053280 was granted and assigned to Regeneron Pharmaceuticals on July, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Current Assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
110532800
Patent Inventor Names
Ankit Vartak0
Erica Pyles0
Ning Li0
Shunhai Wang0
Thomas Daly0
Andrew Tustian0
Nisha Palackal0
Date of Patent
July 6, 2021
0
Patent Application Number
169960070
Date Filed
August 18, 2020
0
Patent Citations
‌
US Patent 10392430 Methods of making nucleic acid molecules encoding modified chimeric polypeptides with improved pharmacokinetic properties
‌
US Patent 10400025 VEGF antagonist formulations suitable for intravitreal administration
‌
US Patent 10406226 Method of manufacturing VEGF antagonist fusion proteins
‌
US Patent 10576128 Liquid formulation of a VEGF antagonist
‌
US Patent 10464992 VEGF antagonist formulations suitable for intravitreal administration
0
‌
US Patent 10626142 Purification platform for bispecific antibodies
‌
US Patent 10646456 Methods of administering amantadine
‌
US Patent 10738130 Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof
...
Patent Citations Received
‌
US Patent 12103960 VEGF traps and mini-traps and methods for treating ocular disorders and cancer
0
‌
US Patent 11459374 Anti-VEGF protein compositions and methods for producing the same
‌
US Patent 11485770 Anti-VEGF protein compositions and methods for producing the same
‌
US Patent 11505593 Anti-VEGF protein compositions and methods for producing the same
0
‌
US Patent 11299532 Anti-VEGF protein compositions and methods for producing the same
‌
US Patent 11306135 Anti-VEGF protein compositions and methods for producing the same
0
‌
US Patent 11753459 Anti-VEGF protein compositions and methods for producing the same
‌
US Patent 11958894 Anti-VEGF protein compositions and methods for producing the same
0
...
Patent Primary Examiner
‌
Jeffrey E. Russel
0
Patent abstract

The present disclosure pertains to compositions comprising aflibercept and methods for producing such compositions in chemically defined media and using chromatography to reduce amounts of certain aflibercept variants.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11053280 Anti-VEGF protein compositions and methods for producing the same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.